Upstream nickel resource development projects gradually reaching full production zhejiang huayou cobalt Q3 net profit hits historical high for the same period | interpretations
Thanks to the simultaneous rise in the volume and price of nickel products, zhejiang huayou cobalt's performance has stabilized, with Q3 net profit hitting the highest level in a single quarter this year; In the first three quarters of this year, zhejiang huayou cobalt's net profit has reached 90% of last year's annual net profit, and the full-year performance may exceed market expectations; In the first three quarters of this year, zhejiang huayou cobalt's financial expenses increased by 88.64% year-on-year, possibly related to the high corporate debt ratio.
TCL Huaxing's new ace is coming.
The first printed oled product is expected to be officially mass-produced by the end of the year.
It is expected that relevant national authorities will establish a low-altitude economic regulatory bureau.
①The establishment decision has been approved, and the new bureau is currently in preparation; ② The low-altitude economy set up a dedicated bureau, which can better coordinate resources at all levels to promote industrial development.
Policy is bullish, why did the real estate sector fall instead? Public interpretation of the meeting of the Ministry of Housing and Urban-Rural Development and other five departments.
Why did the real estate sector fall despite the bullish news? Discuss the Ministry of Housing and Urban-Rural Development's new policy of 'two increases' that is popular among public funds. Institutions point out that the combination of the Ministry of Housing and Urban-Rural Development meeting and fiscal debt policy reflects the strength of the policies.
Listed insurance companies achieved a record high net profit growth rate in the third quarter! china life insurance increased by over 165% year-on-year, with adjustments to the base number due to different accounting standards between old and new systems.
①China Life Insurance announced that the net income attributable to the parent company in the first three quarters increased by approximately 165% to 185% year-on-year, including the impact of the replacement of old and new accounting standards; ②China Life Insurance, New China Life Insurance, the People's Insurance, and China Pacific Insurance have all disclosed third-quarter pre-increase announcements, with China Life Insurance showing the largest performance increase; ③All four listed insurance companies have indicated that the recent rebound in capital markets has increased investment income significantly year-on-year, which is then reflected in profits.
Hengrui PD-1 monoclonal antibody has once again submitted an application for listing in the USA. Will it replicate the approval path of Keytruda monoclonal antibody? | Speed Reading Announcement
①Today, jiangsu hengrui pharmaceuticals announced that it will resubmit the application for approval of Carirelizumab in the USA, after previously receiving a Complete Response Letter (CRL) from the US FDA, causing a delay; ②Junshi Bio's PD-1 variety also experienced delays in the USA but eventually succeeded in getting approved, industry insiders suggest that hengrui may replicate this process; ③If successfully approved in the USA, it would be of great significance to hengrui pharmaceuticals' global strategy.